Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
    December 2021
  1. HOY J, McMahon J
    Is it time for injectable antiretroviral therapy for HIV?
    Lancet. 2021;396:1944-1946.
    >> Share

  2. OVERTON ET, Richmond G, Rizzardini G, Jaeger H, et al
    Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.
    Lancet. 2021;396:1994-2005.
    >> Share

    January 2021
  3. SINGH NS, Ataullahjan A, Ndiaye K, Das JK, et al
    Delivering health interventions to women, children, and adolescents in conflict settings: what have we learned from ten country case studies?
    Lancet. 2021 Jan 22. pii: S0140-6736(21)00132.
    >> Share

    Expanding HIV-positive organ donation.
    Lancet. 2021;397:184-185.
    >> Share

    December 2020
  5. BURKI T
    Cheaper HIV treatment for children.
    Lancet. 2020;396:1873.
    >> Share

  6. VOYSEY M, Clemens SAC, Madhi SA, Weckx LY, et al
    Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32661.
    >> Share

    November 2020
    Maintaining the HIV response in a world shaped by COVID-19.
    Lancet. 2020;396:1703.
    >> Share

  8. BEYRER C, Sullivan P, Adimora AA, Mayer K, et al
    HIV in the USA: priorities for the new administration.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32524.
    >> Share

  9. GOGA A, Bekker LG, Van de Perre P, El-Sadr W, et al
    Centring adolescent girls and young women in the HIV and COVID-19 responses.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32552.
    >> Share

    October 2020
  10. KENYON C
    Syndemic responses to COVID-19 should include an ecological dimension.
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32219.
    >> Share

  11. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    Use of adenovirus type-5 vectored vaccines: a cautionary tale.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32156.
    >> Share

  12. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2020;396:1204-1222.
    >> Share

  13. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2020;396:1160-1203.
    >> Share

  14. MCMAHON JH, Hoy JF, Kamarulzaman A, Bekker LG, et al
    Leveraging the advances in HIV for COVID-19.
    Lancet. 2020;396:943-944.
    >> Share

    September 2020
  15. PHELAN AL, Eccleston-Turner M, Rourke M, Maleche A, et al
    Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access.
    Lancet. 2020 Sep 7. pii: S0140-6736(20)31873.
    >> Share

    August 2020
  16. BUSE K, Nilo A, Kim J, Heywood M, et al
    COVID-19 combination prevention requires attention to structural drivers.
    Lancet. 2020;396:466.
    >> Share

  17. BISSON GP, Bastos M, Campbell JR, Bang D, et al
    Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis.
    Lancet. 2020;396:402-411.
    >> Share

  18. MAYANJA-KIZZA H, Sekaggya-Wiltshire C, Kassa D
    Optimal therapy for multidrug-resistant tuberculosis and HIV.
    Lancet. 2020;396:363-365.
    >> Share

    July 2020
  19. MAYER KH, Molina JM, Thompson MA, Anderson PL, et al
    Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
    Lancet. 2020;396:239-254.
    >> Share

    DISCOVER: much accomplished, but not yet for all.
    Lancet. 2020;396:214-215.
    >> Share

  21. ZHU FC, Guan XH, Li YH, Huang JY, et al
    Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2020 Jul 20. pii: S0140-6736(20)31605.
    >> Share

  22. KAVANAGH MM, Katz IT, Holmes CB
    Reckoning with mortality: global health, HIV, and the politics of data.
    Lancet. 2020 Jul 3. pii: S0140-6736(20)31046.
    >> Share

  23. NAZARETH J, Minhas JS, Jenkins DR, Sahota A, et al
    Early lessons from a second COVID-19 lockdown in Leicester, UK.
    Lancet. 2020 Jul 2. pii: S0140-6736(20)31490.
    >> Share

    May 2020
  24. PURAS D, de Mesquita JB, Cabal L, Maleche A, et al
    The right to health must guide responses to COVID-19.
    Lancet. 2020 May 29. pii: S0140-6736(20)31255.
    >> Share

  25. KAVANAGH MM, Erondu NA, Tomori O, Dzau VJ, et al
    Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics.
    Lancet. 2020 May 7. pii: S0140-6736(20)31093.
    >> Share

    April 2020
  26. POZNIAK A, Bekker LG, Kamarulzaman A, Gandhi M, et al
    A COVID-19 conference at AIDS 2020: Virtual.
    Lancet. 2020 Apr 30. pii: S0140-6736(20)31026.
    >> Share

  27. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30608.
    >> Share

  28. SUNDEWALL J, Forsberg BC
    Understanding health spending for SDG 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30963.
    >> Share

  29. PAREEK M, Bangash MN, Pareek N, Pan D, et al
    Ethnicity and COVID-19: an urgent public health research priority.
    Lancet. 2020 Apr 21. pii: S0140-6736(20)30922.
    >> Share

  30. CORNELL M, Horton K, Colvin C, Medina-Marino A, et al
    Perpetuating gender inequity through uneven reporting.
    Lancet. 2020;395:1258.
    >> Share

    March 2020
    Building on the PrEP victory.
    Lancet. 2020;395:1012.
    >> Share

  32. MARTINEZ L, Cords O, Horsburgh CR, Andrews JR, et al
    The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis.
    Lancet. 2020;395:973-984.
    >> Share

  33. LANE R
    Sean Wasserman: rising star in TB-HIV research and medicine.
    Lancet. 2020;395:941.
    >> Share

  34. KROWN SE, Moser CB, MacPhail P, Matining RM, et al
    Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
    Lancet. 2020 Mar 5. pii: S0140-6736(19)33222.
    >> Share

  35. FREEMAN EE, McMahon DE, Laker-Oketta M
    Time to address disparities in the standard of care for Kaposi sarcoma.
    Lancet. 2020 Mar 5. pii: S0140-6736(20)30473.
    >> Share

    February 2020
  36. CLARK H, Coll-Seck AM, Banerjee A, Peterson S, et al
    A future for the world's children? A WHO-UNICEF-Lancet Commission.
    Lancet. 2020;395:605-658.
    >> Share

  37. FIDLER S, Stohr W, Pace M, Dorrell L, et al
    Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial.
    Lancet. 2020 Feb 18. pii: S0140-6736(19)32990.
    >> Share

  38. LEWIN SR, Rasmussen TA
    Kick and kill for HIV latency.
    Lancet. 2020 Feb 18. pii: S0140-6736(20)30264.
    >> Share

  39. BURKI T
    UNAIDS and IAEA join forces on HIV and cervical cancer.
    Lancet. 2020;395:484.
    >> Share

  40. BAETEN JM, Kiarie J, Mastro TD, Mugo NR, et al
    ECHO: context and limitations - Authors' reply.
    Lancet. 2020;395:e27.
    >> Share

  41. JEWELL BL, Smith JA, Padian NS, van de Wijgert JHHM, et al
    ECHO: context and limitations.
    Lancet. 2020;395:e25-e26.
    >> Share

  42. GOLLUB EL, Stein Z, van de Wijgert JHHM, Jones H, et al
    ECHO: context and limitations.
    Lancet. 2020;395:e24.
    >> Share

  43. MARRAZZO J, Balkus JE, Achilles S, Noguchi L, et al
    ECHO: context and limitations.
    Lancet. 2020;395:e23.
    >> Share

    ECHO: context and limitations.
    Lancet. 2020;395:e22.
    >> Share

  45. MIGUEL RDV, Calla NEQ, Aceves KM, Lopez FCD, et al
    ECHO: context and limitations.
    Lancet. 2020;395:e21.
    >> Share

    January 2020
  46. KHAN M
    Pakistan's children need better protection by the health-care system.
    Lancet. 2020;395:185.
    >> Share

    December 2019
    The elusive end to HIV in the USA.
    Lancet. 2019;394:2125.
    >> Share

  48. BEKKER LG, Tatoud R, Dabis F, Feinberg M, et al
    The complex challenges of HIV vaccine development require renewed and expanded global commitment.
    Lancet. 2019 Dec 2. pii: S0140-6736(19)32682.
    >> Share

    November 2019
    Dolutegravir: advancing ethical research in pregnancy.
    Lancet. 2019;394:1972-1974.
    >> Share

  50. DEVI S
    Stigma, politics, and an epidemic: HIV in the Philippines.
    Lancet. 2019 Nov 29. pii: S0140-6736(19)32939.
    >> Share

  51. JADAVJI T, Lang R, Gill MJ
    Protecting the health of children moving to Canada.
    Lancet. 2019 Nov 5. pii: S0140-6736(19)31913.
    >> Share

    October 2019
  52. DEGENHARDT L, Grebely J, Stone J, Hickman M, et al
    Global patterns of opioid use and dependence: harms to populations, interventions, and future action.
    Lancet. 2019;394:1560-1579.
    >> Share

  53. FARRELL M, Martin NK, Stockings E, Borquez A, et al
    Responding to global stimulant use: challenges and opportunities.
    Lancet. 2019 Oct 21. pii: S0140-6736(19)32230.
    >> Share

  54. TCHIOMBIANO S, Delfraissy JF, Dabis F
    The Global Fund's Sixth Replenishment Conference: a challenge for France, a challenge for global health.
    Lancet. 2019;394:1214-1215.
    >> Share

    August 2019
    Sexual violence, HIV, and conflict in South Sudan.
    Lancet. 2019;394:723-724.
    >> Share

  56. DUKE T
    What the PERCH study means for future pneumonia strategies.
    Lancet. 2019;394:714-716.
    >> Share

  57. REID MJA, Goosby E
    A tuberculosis-free world: is it a delusion? - Authors' reply.
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31411.
    >> Share

  58. SATOH S, Boyer E
    HIV in South Africa.
    Lancet. 2019;394:467.
    >> Share

    July 2019
  59. NOGUCHI LM, Simelela PN
    How should we listen to ECHO?
    Lancet. 2019;394:275-276.
    >> Share

  60. HEADLEY J, Gustav R, Kavanagh MM, Mworeko L, et al
    Leading UNAIDS: a once-in-a-generation challenge?
    Lancet. 2019 Jul 10. pii: S0140-6736(19)31628.
    >> Share

    June 2019

  61. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study.
    Lancet. 2019 Jun 27. pii: S0140-6736(19)30721.
    >> Share

  62. DE SANJOSE S, Delany-Moretlwe S
    HPV vaccines can be the hallmark of cancer prevention.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30549.
    >> Share

  63. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Lancet. 2019 Jun 13. pii: S0140-6736(19)31288.
    >> Share

  64. GREEN A
    HIV epidemic in children in Pakistan raises concern.
    Lancet. 2019;393:2288.
    >> Share

    May 2019
  65. FRIEBEL R, Silverman R, Glassman A, Chalkidou K, et al
    On results reporting and evidentiary standards: spotlight on the Global Fund.
    Lancet. 2019;393:2006-2008.
    >> Share

  66. MAKONI M
    Health under the spotlight as South Africa takes to the polls.
    Lancet. 2019;393:1791-1792.
    >> Share

  67. RODGER AJ, Cambiano V, Bruun T, Vernazza P, et al
    Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
    Lancet. 2019 May 2. pii: S0140-6736(19)30418.
    >> Share

  68. KIRKCALDY RD, Workowski KA
    Gentamicin as an alternative treatment for gonorrhoea.
    Lancet. 2019 May 2. pii: S0140-6736(19)30244.
    >> Share

  69. ROSS JDC, Brittain C, Cole M, Dewsnap C, et al
    Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Lancet. 2019 May 2. pii: S0140-6736(18)32817.
    >> Share

  70. COHEN MS
    Successful treatment of HIV eliminates sexual transmission.
    Lancet. 2019 May 2. pii: S0140-6736(19)30701.
    >> Share

    April 2019
  71. BEKKER LG, Beyrer C, Isbell M
    The HIV response and global health - Authors' reply.
    Lancet. 2019;393:1697.
    >> Share

  72. GLASS RI, El-Sadr W, Goosby E, Kupfer LE, et al
    The HIV response and global health.
    Lancet. 2019;393:1696.
    >> Share

  73. GUISE A
    The HIV response and global health.
    Lancet. 2019;393:1695-1696.
    >> Share

  74. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050.
    Lancet. 2019 Apr 24. pii: S0140-6736(19)30841.
    >> Share

  75. FRASER B
    Providing care for trans women with HIV/AIDS in Peru.
    Lancet. 2019;393:1399-1400.
    >> Share

    March 2019
  76. KIRBY T
    Anthony Fauci: fighting HIV/AIDS from the beginning.
    Lancet. 2019;393:1195.
    >> Share

  77. KIRBY T
    Second person reported in remission from HIV infection.
    Lancet. 2019;393:1191.
    >> Share

  78. KAJUBI R, Ochieng T, Kakuru A, Jagannathan P, et al
    Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32224.
    >> Share

  79. REID MJA, Arinaminpathy N, Bloom A, Bloom BR, et al
    Building a tuberculosis-free world: The Lancet Commission on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30024.
    >> Share

  80. WATTS G
    Christine Sekaggya-Wiltshire: prizewinner in HIV-tuberculosis research.
    Lancet. 2019 Mar 19. pii: S0140-6736(19)30644.
    >> Share

  81. BOLLYKY TJ, Templin T, Cohen M, Schoder D, et al
    The relationships between democratic experience, adult health, and cause-specific mortality in 170 countries between 1980 and 2016: an observational analysis.
    Lancet. 2019 Mar 13. pii: S0140-6736(19)30235.
    >> Share

  82. PAGE KR, Doocy S, Reyna Ganteaume F, Castro JS, et al
    Venezuela's public health crisis: a regional emergency.
    Lancet. 2019 Mar 11. pii: S0140-6736(19)30344.
    >> Share

    Ending HIV in the USA.
    Lancet. 2019;393:960.
    >> Share

    February 2019
    Russia's burgeoning HIV epidemic.
    Lancet. 2019;393:612.
    >> Share

  85. JAFFE S
    USA sets goal to end the HIV epidemic in a decade.
    Lancet. 2019;393:625-626.
    >> Share

  86. CARRAT F, Fontaine H, Dorival C, Simony M, et al
    Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
    Lancet. 2019 Feb 11. pii: S0140-6736(18)32111.
    >> Share

  87. COE IR, Wiley R, Bekker LG
    Organisational best practices towards gender equality in science and medicine.
    Lancet. 2019;393:587-593.
    >> Share

  88. GOSTIN L, Phelan A, Coutinho AG, Eccleston-Turner M, et al
    Ebola in the Democratic Republic of the Congo: time to sound a global alert?
    Lancet. 2019 Feb 1. pii: S0140-6736(19)30243.
    >> Share

    January 2019
  89. MICHAUD J, Moss K, Licina D, Waldman R, et al
    Militaries and global health: peace, conflict, and disaster response.
    Lancet. 2019;393:276-286.
    >> Share

  90. KROIDL A, Eberle J
    A two-drug regimen for antiretroviral therapy.
    Lancet. 2019;393:106-108.
    >> Share

    December 2018
  91. KIRBY T
    The UK reaches UNAIDS 90-90-90 targets.
    Lancet. 2018;392:2427.
    >> Share

    CRISPR-Cas9: a world first?
    Lancet. 2018;392:2413.
    >> Share

  93. ZHANG L, Zhong P, Zhai X, Shao Y, et al
    Open letter from Chinese HIV professionals on human genome editing.
    Lancet. 2018 Dec 3. pii: S0140-6736(18)33082.
    >> Share

  94. PETRONI S, Ngo TD
    Stemming HIV in adolescents: gender and modes of transmission.
    Lancet. 2018;392:2335-2336.
    >> Share

  95. ADEYEYE AO, Stirratt MJ, Burns DN
    Engaging men in HIV treatment and prevention.
    Lancet. 2018;392:2334-2335.
    >> Share

    November 2018
  96. KIRBY T
    Susan Buchbinder: driving HIV prevention efforts worldwide.
    Lancet. 2018;392:2161.
    >> Share

  97. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2018;392:1684-1735.
    >> Share

  98. CAHN P, Madero JS, Arribas JR, Antinori A, et al
    Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-infe
    Lancet. 2018 Nov 9. pii: S0140-6736(18)32462.
    >> Share

  99. HAAKENSTAD A, Moses M, Dieleman JL
    Comparing estimates of spending on health and HIV/AIDS - Authors' reply.
    Lancet. 2018;392:1622.
    >> Share

  100. IZAZOLA-LICEA JA, Yakusik A, Mattur D
    Comparing estimates of spending on health and HIV/AIDS.
    Lancet. 2018;392:1621-1622.
    >> Share

    October 2018
  101. FOREMAN KJ, Marquez N, Dolgert A, Fukutaki K, et al
    Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.
    Lancet. 2018 Oct 16. pii: S0140-6736(18)31694.
    >> Share

    September 2018
  102. AHMAD N, Ahuja SD, Akkerman OW, Alffenaar JC, et al
    Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet. 2018;392:821-834.
    >> Share

  103. MILLER WC, Hoffman IF, Hanscom BS, Ha TV, et al
    A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
    Lancet. 2018;392:747-759.
    >> Share

  104. JARLAIS DCD, Duong HT
    Ending HIV epidemics among people who inject drugs in LMICs.
    Lancet. 2018;392:714-716.
    >> Share

    August 2018
  105. BELETSKY L, Baker P, Arredondo J, Emuka A, et al
    The global health and equity imperative for safe consumption facilities.
    Lancet. 2018;392:553-554.
    >> Share

  106. MCCALL B
    Scientific evidence against HIV criminalisation.
    Lancet. 2018;392:543-544.
    >> Share

  107. BURZA S, Croft SL, Boelaert M
    Lancet. 2018 Aug 17. pii: S0140-6736(18)31204.
    >> Share

    July 2018
  108. GHOSN J, Taiwo B, Seedat S, Autran B, et al
    Lancet. 2018 Jul 23. pii: S0140-6736(18)31311.
    >> Share

  109. BAROUCH DH, Tomaka FL, Wegmann F, Stieh DJ, et al
    Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
    Lancet. 2018;392:232-243.
    >> Share

  110. PAVLAKIS GN, Felber BK
    A new step towards an HIV/AIDS vaccine.
    Lancet. 2018;392:192-194.
    >> Share

  111. WEBSTER P
    PEPFAR at 15 years.
    Lancet. 2018;392:200.
    >> Share

  112. NAKKAZI E
    Changes to dolutegravir policy in several African countries.
    Lancet. 2018;392:199.
    >> Share

  113. SHANNON K, Crago AL, Baral SD, Bekker LG, et al
    The global response and unmet actions for HIV and sex workers.
    Lancet. 2018 Jul 20. pii: S0140-6736(18)31439.
    >> Share

  114. DAS P, Horton R
    Beyond the silos: integrating HIV and global health.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31466.
    >> Share

  115. MAKOFANE K, Spire B, Mtetwa P
    Tackling global health inequities in the HIV response.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31441.
    >> Share

  116. SANDS P
    HIV: from exceptionalism to endgame.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31434.
    >> Share

  117. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
    >> Share

    New strategies for inpatients with HIV and tuberculosis.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
    >> Share

  119. BEKKER LG, Alleyne G, Baral S, Cepeda J, et al
    Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31070.
    >> Share

    June 2018
    Dolutegravir for HIV: a lesson in pregnancy safety research.
    Lancet. 2018;391:2296.
    >> Share

  121. MCBRIDE B, Mitra S, Kondo V, Elmi H, et al
    Unpaid labour, #MeToo, and young women in global health.
    Lancet. 2018;391:2192-2193.
    >> Share

    Active case finding for communicable diseases in prisons.
    Lancet. 2018;391:2186.
    >> Share

    May 2018
  123. NISHTAR S, Niinisto S, Sirisena M, Vazquez T, et al
    Time to deliver: report of the WHO Independent High-Level Commission on NCDs.
    Lancet. 2018 May 31. pii: S0140-6736(18)31258.
    >> Share

    HIV/AIDS community divided over allegations about UNAIDS.
    Lancet. 2018;391:1984.
    >> Share

    April 2018
    The Global Fund links with Lombard Odier bank.
    Lancet. 2018;391:1674-1675.
    >> Share

    Claims of sexual harassment and assault threaten UN agency.
    Lancet. 2018;391:1561-1565.
    >> Share

  127. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.
    Lancet. 2018 Apr 17. pii: S0140-6736(18)30698.
    >> Share

    March 2018
  128. OLAKUNDE BO, Adeyinka DA, Wakdok SS, Oladele TT, et al
    Quantification of the effect of terrorism on the HIV response in Nigeria.
    Lancet. 2018;391:1257-1258.
    >> Share

  129. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    >> Share

  130. BROWNE JL, Smit MR, Angira F, van der Graaf R, et al
    Good intentions do not replace ethical conduct in research.
    Lancet. 2018;391:1020-1021.
    >> Share

    February 2018
  131. THAPA S
    Women helping women prevent HIV in resource-limited settings.
    Lancet. 2018;391:738-739.
    >> Share

    January 2018
  132. KARAMOUZIAN M, Kerr T
    A public health approach to opioid addiction in North America.
    Lancet. 2018;391:201-202.
    >> Share

  133. LLIBRE JM, Hung CC, Brinson C, Castelli F, et al
    Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies.
    Lancet. 2018 Jan 5. pii: S0140-6736(17)33095.
    >> Share

  134. BICCARD BM, Madiba TE, Kluyts HL, Munlemvo DM, et al
    Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study.
    Lancet. 2018 Jan 3. pii: S0140-6736(18)30001.
    >> Share

    December 2017
  135. BERNARDO EL, Fuente-Soro L, Lopez-Varela E, Naniche D, et al
    Anonymity in HIV testing: implications for public health.
    Lancet. 2017;390:2546.
    >> Share

    October 2017
  136. LAMONTAGNE F, Fowler RA, Adhikari NK, Murthy S, et al
    Evidence-based guidelines for supportive care of patients with Ebola virus disease.
    Lancet. 2017 Oct 17. pii: S0140-6736(17)31795.
    >> Share

  137. IYER JK, Mendelson M
    Can the Antimicrobial Resistance Benchmark blaze a new trail?
    Lancet. 2017 Oct 13. pii: S0140-6736(17)32670.
    >> Share

    September 2017
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    >> Share

    Health in the Soviet Union and in the post-Soviet space: from utopia to collapse and arduous recovery.
    Lancet. 2017;390:1611-1612.
    >> Share

  140. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2017;390:1151-1210.
    >> Share

  141. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2017;390:1084-1150.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016